Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLong term obesity drug use could hurt the food industry, says Morgan Stanley's Pam KaufmanPam Kaufman, equity research analyst at Morgan Stanley, joins 'The Exchange' to discuss the impact of obesity drugs on the food and beverage sector, what companies might be hurt by a possible pullback in appetite brought on by obesity drug use and what food companies could benefit from a shift in consumer eating habits.
Persons:
Morgan Stanley's Pam Kaufman Pam Kaufman, Morgan Stanley